Last Updated on November 26, 2024 by admin
Packaging design retains sustainable and practical elements with emerging trends in the Pharma market for 2025.
Label Craft are always looking for ways to keep ahead of emerging trends. In a time marked by technological advancements, regulatory change and shifting consumer demand, several trends are ready to hit the pharmaceutical market. We are here to make sure our packaging moves along with each trend, for both sustainability and security at all times for end users.
Revolutionary drug delivery systems.
Antimicrobial resistance (AMR) poses a pervasive danger to worldwide public health having directly caused an estimated 1.27 million deaths and nearly 5 million indirectly. This critical issue is a fundamental driving force for ongoing research and developments, affecting all stakeholders universally.
One of the main drivers of AMR is the often-unintended misuse of drugs by patients, known as patient non-adherence, including forgetfulness, avoiding unpleasant side effects, cost, lack of education, and a false sense of security when symptoms ease.
Packaging design is evolving to address these issues with inventions such as pre-filled syringes, auto-injectors, and inhalers, making it easier for patients to take prescribed medicines.
Other innovations in smart packaging solutions deliver patients with trackers and reminders to take medications on time and to completion. Smart blister packs are one example of this, with a built-in ability to capture use-related data and send reminders of when the next dosages are due.
The required commitment to child-resistant packaging (CRP) creates another barrier to patient adherence for those with disabilities such as blindness or reduced dexterity.
But innovations in CRP are attempting to remedy this, with bottle lids that need moistening to be opened, laser perforation in packaging requiring two-way tearing motions, zip lock and flap designs, and technology designed to distort depth perception, which confuses children.
2025 could also see the rise of biologics, diverse medical products or medicines derived from living organisms that may be used to treat a variety of medical conditions for which there are no other treatment options available.
Ongoing development into new drug delivery systems and their packaging will be necessary to accommodate its growth, necessitating especially flexible filling and packaging equipment while safety concerns will demand innovation in containment solutions and barrier technologies.
Manufacturers who hope to thrive in this fast-evolving field must offer smart value-added features to strike exclusive deals in response to demand.
Due to the high worth of biotech products, the counterfeit market aims to claim a share of the earnings. Ensuring security and transparency in the supply chain remains pivotal for packaging manufacturers and the pharmaceutical industry at large, prompting the sweeping integration of defensive measures within smart packaging designs.
With the growing prevalence and enhanced capabilities of artificial intelligence (AI) technology, its use in conjunction with blockchain technology will further facilitate real-time monitoring and securing of supply chains by spotting irregularities and potential risks as and when they happen.
Today’s advanced technology gives power to those wishing to use it for good, but also to those with bad motives. Unfortunately, counterfeit pharmaceuticals are on the rise globally.
Blockchain is part of the solution to this problem with its ability to serialize each drug with an unchangeable and unique identifier tag. This allows stakeholders to verify a drug’s authenticity and track its origin, preventing the distribution of counterfeit drugs into the market.
Watch this space, as part of The Asteria Group it will no doubt be both an interesting and progressive year!
